Global Rheumatic Disorders Treatment Supply, Demand and Key Producers, 2023-2029

February 2023 | 114 pages | ID: GD68397EC2FBEN
GlobalInfoResearch

Abstracts

The global Rheumatic Disorders Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Rheumatic Disorders Treatment production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Rheumatic Disorders Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rheumatic Disorders Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Rheumatic Disorders Treatment total production and demand, 2018-2029, (K Units)

Global Rheumatic Disorders Treatment total production value, 2018-2029, (USD Million)

Global Rheumatic Disorders Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Rheumatic Disorders Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Rheumatic Disorders Treatment domestic production, consumption, key domestic manufacturers and share

Global Rheumatic Disorders Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Rheumatic Disorders Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Rheumatic Disorders Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Rheumatic Disorders Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia and Orencia, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rheumatic Disorders Treatment market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Rheumatic Disorders Treatment Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Rheumatic Disorders Treatment Market, Segmentation by Type

• Acts on TNF-?
• Acts on Interleukins and Interleukin Receptors
• Act on Protein Kinase
• Against Cell Surface Antigens
• Acts on Hormones and Hormone Receptors

Global Rheumatic Disorders Treatment Market, Segmentation by Application

• Hospital
• Pharmacy
• Other

Companies Profiled:

• Humira
• Enbrel
• Simponi
• Remicade
• Rituxan
• Stelara
• Cosentyx
• Prolia
• Orencia
• Actemra
• Benlysta
• Forteo

Key Questions Answered

1. How big is the global Rheumatic Disorders Treatment market?

2. What is the demand of the global Rheumatic Disorders Treatment market?

3. What is the year over year growth of the global Rheumatic Disorders Treatment market?

4. What is the production and production value of the global Rheumatic Disorders Treatment market?

5. Who are the key producers in the global Rheumatic Disorders Treatment market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Rheumatic Disorders Treatment Introduction
1.2 World Rheumatic Disorders Treatment Supply & Forecast
  1.2.1 World Rheumatic Disorders Treatment Production Value (2018 & 2022 & 2029)
  1.2.2 World Rheumatic Disorders Treatment Production (2018-2029)
  1.2.3 World Rheumatic Disorders Treatment Pricing Trends (2018-2029)
1.3 World Rheumatic Disorders Treatment Production by Region (Based on Production Site)
  1.3.1 World Rheumatic Disorders Treatment Production Value by Region (2018-2029)
  1.3.2 World Rheumatic Disorders Treatment Production by Region (2018-2029)
  1.3.3 World Rheumatic Disorders Treatment Average Price by Region (2018-2029)
  1.3.4 North America Rheumatic Disorders Treatment Production (2018-2029)
  1.3.5 Europe Rheumatic Disorders Treatment Production (2018-2029)
  1.3.6 China Rheumatic Disorders Treatment Production (2018-2029)
  1.3.7 Japan Rheumatic Disorders Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Rheumatic Disorders Treatment Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Rheumatic Disorders Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Rheumatic Disorders Treatment Demand (2018-2029)
2.2 World Rheumatic Disorders Treatment Consumption by Region
  2.2.1 World Rheumatic Disorders Treatment Consumption by Region (2018-2023)
  2.2.2 World Rheumatic Disorders Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Rheumatic Disorders Treatment Consumption (2018-2029)
2.4 China Rheumatic Disorders Treatment Consumption (2018-2029)
2.5 Europe Rheumatic Disorders Treatment Consumption (2018-2029)
2.6 Japan Rheumatic Disorders Treatment Consumption (2018-2029)
2.7 South Korea Rheumatic Disorders Treatment Consumption (2018-2029)
2.8 ASEAN Rheumatic Disorders Treatment Consumption (2018-2029)
2.9 India Rheumatic Disorders Treatment Consumption (2018-2029)

3 WORLD RHEUMATIC DISORDERS TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Rheumatic Disorders Treatment Production Value by Manufacturer (2018-2023)
3.2 World Rheumatic Disorders Treatment Production by Manufacturer (2018-2023)
3.3 World Rheumatic Disorders Treatment Average Price by Manufacturer (2018-2023)
3.4 Rheumatic Disorders Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Rheumatic Disorders Treatment Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Rheumatic Disorders Treatment in 2022
  3.5.3 Global Concentration Ratios (CR8) for Rheumatic Disorders Treatment in 2022
3.6 Rheumatic Disorders Treatment Market: Overall Company Footprint Analysis
  3.6.1 Rheumatic Disorders Treatment Market: Region Footprint
  3.6.2 Rheumatic Disorders Treatment Market: Company Product Type Footprint
  3.6.3 Rheumatic Disorders Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Rheumatic Disorders Treatment Production Value Comparison
  4.1.1 United States VS China: Rheumatic Disorders Treatment Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Rheumatic Disorders Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Rheumatic Disorders Treatment Production Comparison
  4.2.1 United States VS China: Rheumatic Disorders Treatment Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Rheumatic Disorders Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Rheumatic Disorders Treatment Consumption Comparison
  4.3.1 United States VS China: Rheumatic Disorders Treatment Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Rheumatic Disorders Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Rheumatic Disorders Treatment Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Rheumatic Disorders Treatment Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Rheumatic Disorders Treatment Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Rheumatic Disorders Treatment Production (2018-2023)
4.5 China Based Rheumatic Disorders Treatment Manufacturers and Market Share
  4.5.1 China Based Rheumatic Disorders Treatment Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Rheumatic Disorders Treatment Production Value (2018-2023)
  4.5.3 China Based Manufacturers Rheumatic Disorders Treatment Production (2018-2023)
4.6 Rest of World Based Rheumatic Disorders Treatment Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Rheumatic Disorders Treatment Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Rheumatic Disorders Treatment Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Rheumatic Disorders Treatment Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Rheumatic Disorders Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Acts on TNF-?
  5.2.2 Acts on Interleukins and Interleukin Receptors
  5.2.3 Act on Protein Kinase
  5.2.4 Against Cell Surface Antigens
  5.2.5 Acts on Hormones and Hormone Receptors
5.3 Market Segment by Type
  5.3.1 World Rheumatic Disorders Treatment Production by Type (2018-2029)
  5.3.2 World Rheumatic Disorders Treatment Production Value by Type (2018-2029)
  5.3.3 World Rheumatic Disorders Treatment Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Rheumatic Disorders Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Pharmacy
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Rheumatic Disorders Treatment Production by Application (2018-2029)
  6.3.2 World Rheumatic Disorders Treatment Production Value by Application (2018-2029)
  6.3.3 World Rheumatic Disorders Treatment Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Humira
  7.1.1 Humira Details
  7.1.2 Humira Major Business
  7.1.3 Humira Rheumatic Disorders Treatment Product and Services
  7.1.4 Humira Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Humira Recent Developments/Updates
  7.1.6 Humira Competitive Strengths & Weaknesses
7.2 Enbrel
  7.2.1 Enbrel Details
  7.2.2 Enbrel Major Business
  7.2.3 Enbrel Rheumatic Disorders Treatment Product and Services
  7.2.4 Enbrel Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Enbrel Recent Developments/Updates
  7.2.6 Enbrel Competitive Strengths & Weaknesses
7.3 Simponi
  7.3.1 Simponi Details
  7.3.2 Simponi Major Business
  7.3.3 Simponi Rheumatic Disorders Treatment Product and Services
  7.3.4 Simponi Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Simponi Recent Developments/Updates
  7.3.6 Simponi Competitive Strengths & Weaknesses
7.4 Remicade
  7.4.1 Remicade Details
  7.4.2 Remicade Major Business
  7.4.3 Remicade Rheumatic Disorders Treatment Product and Services
  7.4.4 Remicade Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Remicade Recent Developments/Updates
  7.4.6 Remicade Competitive Strengths & Weaknesses
7.5 Rituxan
  7.5.1 Rituxan Details
  7.5.2 Rituxan Major Business
  7.5.3 Rituxan Rheumatic Disorders Treatment Product and Services
  7.5.4 Rituxan Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Rituxan Recent Developments/Updates
  7.5.6 Rituxan Competitive Strengths & Weaknesses
7.6 Stelara
  7.6.1 Stelara Details
  7.6.2 Stelara Major Business
  7.6.3 Stelara Rheumatic Disorders Treatment Product and Services
  7.6.4 Stelara Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Stelara Recent Developments/Updates
  7.6.6 Stelara Competitive Strengths & Weaknesses
7.7 Cosentyx
  7.7.1 Cosentyx Details
  7.7.2 Cosentyx Major Business
  7.7.3 Cosentyx Rheumatic Disorders Treatment Product and Services
  7.7.4 Cosentyx Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Cosentyx Recent Developments/Updates
  7.7.6 Cosentyx Competitive Strengths & Weaknesses
7.8 Prolia
  7.8.1 Prolia Details
  7.8.2 Prolia Major Business
  7.8.3 Prolia Rheumatic Disorders Treatment Product and Services
  7.8.4 Prolia Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Prolia Recent Developments/Updates
  7.8.6 Prolia Competitive Strengths & Weaknesses
7.9 Orencia
  7.9.1 Orencia Details
  7.9.2 Orencia Major Business
  7.9.3 Orencia Rheumatic Disorders Treatment Product and Services
  7.9.4 Orencia Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Orencia Recent Developments/Updates
  7.9.6 Orencia Competitive Strengths & Weaknesses
7.10 Actemra
  7.10.1 Actemra Details
  7.10.2 Actemra Major Business
  7.10.3 Actemra Rheumatic Disorders Treatment Product and Services
  7.10.4 Actemra Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Actemra Recent Developments/Updates
  7.10.6 Actemra Competitive Strengths & Weaknesses
7.11 Benlysta
  7.11.1 Benlysta Details
  7.11.2 Benlysta Major Business
  7.11.3 Benlysta Rheumatic Disorders Treatment Product and Services
  7.11.4 Benlysta Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Benlysta Recent Developments/Updates
  7.11.6 Benlysta Competitive Strengths & Weaknesses
7.12 Forteo
  7.12.1 Forteo Details
  7.12.2 Forteo Major Business
  7.12.3 Forteo Rheumatic Disorders Treatment Product and Services
  7.12.4 Forteo Rheumatic Disorders Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Forteo Recent Developments/Updates
  7.12.6 Forteo Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Rheumatic Disorders Treatment Industry Chain
8.2 Rheumatic Disorders Treatment Upstream Analysis
  8.2.1 Rheumatic Disorders Treatment Core Raw Materials
  8.2.2 Main Manufacturers of Rheumatic Disorders Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Rheumatic Disorders Treatment Production Mode
8.6 Rheumatic Disorders Treatment Procurement Model
8.7 Rheumatic Disorders Treatment Industry Sales Model and Sales Channels
  8.7.1 Rheumatic Disorders Treatment Sales Model
  8.7.2 Rheumatic Disorders Treatment Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Rheumatic Disorders Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Rheumatic Disorders Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Rheumatic Disorders Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Rheumatic Disorders Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Rheumatic Disorders Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Rheumatic Disorders Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Rheumatic Disorders Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Rheumatic Disorders Treatment Production Market Share by Region (2018-2023)
Table 9. World Rheumatic Disorders Treatment Production Market Share by Region (2024-2029)
Table 10. World Rheumatic Disorders Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Rheumatic Disorders Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Rheumatic Disorders Treatment Major Market Trends
Table 13. World Rheumatic Disorders Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Rheumatic Disorders Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Rheumatic Disorders Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Rheumatic Disorders Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Rheumatic Disorders Treatment Producers in 2022
Table 18. World Rheumatic Disorders Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Rheumatic Disorders Treatment Producers in 2022
Table 20. World Rheumatic Disorders Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Rheumatic Disorders Treatment Company Evaluation Quadrant
Table 22. World Rheumatic Disorders Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Rheumatic Disorders Treatment Production Site of Key Manufacturer
Table 24. Rheumatic Disorders Treatment Market: Company Product Type Footprint
Table 25. Rheumatic Disorders Treatment Market: Company Product Application Footprint
Table 26. Rheumatic Disorders Treatment Competitive Factors
Table 27. Rheumatic Disorders Treatment New Entrant and Capacity Expansion Plans
Table 28. Rheumatic Disorders Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Rheumatic Disorders Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Rheumatic Disorders Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Rheumatic Disorders Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Rheumatic Disorders Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Rheumatic Disorders Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Rheumatic Disorders Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Rheumatic Disorders Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Rheumatic Disorders Treatment Production Market Share (2018-2023)
Table 37. China Based Rheumatic Disorders Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Rheumatic Disorders Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Rheumatic Disorders Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Rheumatic Disorders Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Rheumatic Disorders Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Rheumatic Disorders Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Rheumatic Disorders Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Rheumatic Disorders Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Rheumatic Disorders Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Rheumatic Disorders Treatment Production Market Share (2018-2023)
Table 47. World Rheumatic Disorders Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Rheumatic Disorders Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Rheumatic Disorders Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Rheumatic Disorders Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Rheumatic Disorders Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Rheumatic Disorders Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Rheumatic Disorders Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Rheumatic Disorders Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Rheumatic Disorders Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Rheumatic Disorders Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Rheumatic Disorders Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Rheumatic Disorders Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Rheumatic Disorders Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Rheumatic Disorders Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Humira Basic Information, Manufacturing Base and Competitors
Table 62. Humira Major Business
Table 63. Humira Rheumatic Disorders Treatment Product and Services
Table 64. Humira Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Humira Recent Developments/Updates
Table 66. Humira Competitive Strengths & Weaknesses
Table 67. Enbrel Basic Information, Manufacturing Base and Competitors
Table 68. Enbrel Major Business
Table 69. Enbrel Rheumatic Disorders Treatment Product and Services
Table 70. Enbrel Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Enbrel Recent Developments/Updates
Table 72. Enbrel Competitive Strengths & Weaknesses
Table 73. Simponi Basic Information, Manufacturing Base and Competitors
Table 74. Simponi Major Business
Table 75. Simponi Rheumatic Disorders Treatment Product and Services
Table 76. Simponi Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Simponi Recent Developments/Updates
Table 78. Simponi Competitive Strengths & Weaknesses
Table 79. Remicade Basic Information, Manufacturing Base and Competitors
Table 80. Remicade Major Business
Table 81. Remicade Rheumatic Disorders Treatment Product and Services
Table 82. Remicade Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Remicade Recent Developments/Updates
Table 84. Remicade Competitive Strengths & Weaknesses
Table 85. Rituxan Basic Information, Manufacturing Base and Competitors
Table 86. Rituxan Major Business
Table 87. Rituxan Rheumatic Disorders Treatment Product and Services
Table 88. Rituxan Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Rituxan Recent Developments/Updates
Table 90. Rituxan Competitive Strengths & Weaknesses
Table 91. Stelara Basic Information, Manufacturing Base and Competitors
Table 92. Stelara Major Business
Table 93. Stelara Rheumatic Disorders Treatment Product and Services
Table 94. Stelara Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Stelara Recent Developments/Updates
Table 96. Stelara Competitive Strengths & Weaknesses
Table 97. Cosentyx Basic Information, Manufacturing Base and Competitors
Table 98. Cosentyx Major Business
Table 99. Cosentyx Rheumatic Disorders Treatment Product and Services
Table 100. Cosentyx Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cosentyx Recent Developments/Updates
Table 102. Cosentyx Competitive Strengths & Weaknesses
Table 103. Prolia Basic Information, Manufacturing Base and Competitors
Table 104. Prolia Major Business
Table 105. Prolia Rheumatic Disorders Treatment Product and Services
Table 106. Prolia Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Prolia Recent Developments/Updates
Table 108. Prolia Competitive Strengths & Weaknesses
Table 109. Orencia Basic Information, Manufacturing Base and Competitors
Table 110. Orencia Major Business
Table 111. Orencia Rheumatic Disorders Treatment Product and Services
Table 112. Orencia Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Orencia Recent Developments/Updates
Table 114. Orencia Competitive Strengths & Weaknesses
Table 115. Actemra Basic Information, Manufacturing Base and Competitors
Table 116. Actemra Major Business
Table 117. Actemra Rheumatic Disorders Treatment Product and Services
Table 118. Actemra Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Actemra Recent Developments/Updates
Table 120. Actemra Competitive Strengths & Weaknesses
Table 121. Benlysta Basic Information, Manufacturing Base and Competitors
Table 122. Benlysta Major Business
Table 123. Benlysta Rheumatic Disorders Treatment Product and Services
Table 124. Benlysta Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Benlysta Recent Developments/Updates
Table 126. Forteo Basic Information, Manufacturing Base and Competitors
Table 127. Forteo Major Business
Table 128. Forteo Rheumatic Disorders Treatment Product and Services
Table 129. Forteo Rheumatic Disorders Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Rheumatic Disorders Treatment Upstream (Raw Materials)
Table 131. Rheumatic Disorders Treatment Typical Customers
Table 132. Rheumatic Disorders Treatment Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. Rheumatic Disorders Treatment Picture
Figure 2. World Rheumatic Disorders Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rheumatic Disorders Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Rheumatic Disorders Treatment Production (2018-2029) & (K Units)
Figure 5. World Rheumatic Disorders Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Rheumatic Disorders Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Rheumatic Disorders Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Rheumatic Disorders Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Rheumatic Disorders Treatment Production (2018-2029) & (K Units)
Figure 10. China Rheumatic Disorders Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Rheumatic Disorders Treatment Production (2018-2029) & (K Units)
Figure 12. Rheumatic Disorders Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Rheumatic Disorders Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Rheumatic Disorders Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Rheumatic Disorders Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Rheumatic Disorders Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Rheumatic Disorders Treatment Markets in 2022
Figure 26. United States VS China: Rheumatic Disorders Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Rheumatic Disorders Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rheumatic Disorders Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Rheumatic Disorders Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Rheumatic Disorders Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Rheumatic Disorders Treatment Production Market Share 2022
Figure 32. World Rheumatic Disorders Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Rheumatic Disorders Treatment Production Value Market Share by Type in 2022
Figure 34. Acts on TNF-?
Figure 35. Acts on Interleukins and Interleukin Receptors
Figure 36. Act on Protein Kinase
Figure 37. Against Cell Surface Antigens
Figure 38. Acts on Hormones and Hormone Receptors
Figure 39. World Rheumatic Disorders Treatment Production Market Share by Type (2018-2029)
Figure 40. World Rheumatic Disorders Treatment Production Value Market Share by Type (2018-2029)
Figure 41. World Rheumatic Disorders Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Rheumatic Disorders Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Rheumatic Disorders Treatment Production Value Market Share by Application in 2022
Figure 44. Hospital
Figure 45. Pharmacy
Figure 46. Other
Figure 47. World Rheumatic Disorders Treatment Production Market Share by Application (2018-2029)
Figure 48. World Rheumatic Disorders Treatment Production Value Market Share by Application (2018-2029)
Figure 49. World Rheumatic Disorders Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Rheumatic Disorders Treatment Industry Chain
Figure 51. Rheumatic Disorders Treatment Procurement Model
Figure 52. Rheumatic Disorders Treatment Sales Model
Figure 53. Rheumatic Disorders Treatment Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source